Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial JT Santoso, JA Lucci, RL Coleman, I Schafer, EV Hannigan Cancer chemotherapy and pharmacology 52, 13-18, 2003 | 290 | 2003 |
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology … R Lanciano, A Calkins, BN Bundy, G Parham, JA Lucci III, DH Moore, ... Journal of clinical oncology 23 (33), 8289-8295, 2005 | 246 | 2005 |
Interleukin 2 Production in Vitro by Peripheral Lymphocytes in Response to Human Papillomavirus-derived Peptides: Correlation with Cervical Pathology T Tsukui, A Hildesheim, MH Schiffman, J Lucci III, D Contois, P Lawler, ... Cancer research 56 (17), 3967-3974, 1996 | 242 | 1996 |
Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients SK Lutgendorf, AZ Weinrib, F Penedo, D Russell, K DeGeest, ... Journal of Clinical Oncology 26 (29), 4820-4827, 2008 | 228 | 2008 |
Depression, social support, and beta-adrenergic transcription control in human ovarian cancer SK Lutgendorf, K DeGeest, CY Sung, JM Arevalo, F Penedo, J Lucci III, ... Brain, behavior, and immunity 23 (2), 176-183, 2009 | 227 | 2009 |
Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of … T Gatanaga, CD Hwang, W Kohr, F Cappuccini, JA Lucci 3rd, EW Jeffes, ... Proceedings of the National Academy of Sciences 87 (22), 8781-8784, 1990 | 219 | 1990 |
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients … G Thomas, S Ali, FJP Hoebers, KM Darcy, WH Rodgers, M Patel, ... Gynecologic oncology 108 (2), 317-325, 2008 | 217 | 2008 |
Social influences on clinical outcomes of patients with ovarian cancer SK Lutgendorf, K De Geest, D Bender, A Ahmed, MJ Goodheart, ... Journal of Clinical Oncology 30 (23), 2885-2890, 2012 | 216 | 2012 |
Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study KY Look, A Sandler, JA Blessing, JA Lucci III, PG Rose Gynecologic oncology 92 (2), 644-647, 2004 | 196 | 2004 |
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma SK Lutgendorf, DM Lamkin, NB Jennings, JMG Arevalo, F Penedo, ... Clinical Cancer Research 14 (21), 6839-6846, 2008 | 194 | 2008 |
Bombesin stimulates nuclear factor κB activation and expression of proangiogenic factors in prostate cancer cells L Levine, JA Lucci III, B Pazdrak, JZ Cheng, YS Guo, CM Townsend Jr, ... Cancer research 63 (13), 3495-3502, 2003 | 177 | 2003 |
Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis L Clevenger, A Schrepf, K DeGeest, D Bender, M Goodheart, A Ahmed, ... Cancer 119 (17), 3234-3241, 2013 | 161 | 2013 |
Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma … PA DiSilvestro, S Ali, PS Craighead, JA Lucci, YC Lee, DE Cohn, ... Journal of clinical oncology 32 (5), 458-464, 2014 | 155 | 2014 |
Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability A Schrepf, L Clevenger, D Christensen, K DeGeest, D Bender, A Ahmed, ... Brain, behavior, and immunity 30, S126-S134, 2013 | 155 | 2013 |
Disparities in survival among women with invasive cervical cancer: a problem of access to care KF Brookfield, MC Cheung, J Lucci, LE Fleming, LG Koniaris Cancer 115 (1), 166-178, 2009 | 133 | 2009 |
Malnutrition as a predictor of poor postoperative outcomes in gynecologic cancer patients ASQ Kathiresan, KF Brookfield, SI Schuman, JA Lucci Archives of gynecology and obstetrics 284, 445-451, 2011 | 101 | 2011 |
Women with HIV are more commonly infected with non-16 and-18 high-risk HPV types ND McKenzie, EN Kobetz, J Hnatyszyn, LB Twiggs, JA Lucci III Gynecologic oncology 116 (3), 572-577, 2010 | 95 | 2010 |
Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study SE Waggoner, KM Darcy, B Fuhrman, G Parham, J Lucci III, BJ Monk, ... Gynecologic oncology 103 (3), 853-858, 2006 | 91 | 2006 |
Atypical glandular cells: new Bethesda terminology and management guidelines L Levine, JA Lucci III, T Van Dinh Obstetrical & gynecological survey 58 (6), 399-406, 2003 | 87 | 2003 |
Stress management effects on perceived stress and cervical neoplasia in low-income HIV-infected women MH Antoni, DB Pereira, I Marion, N Ennis, MP Andrasik, R Rose, ... Journal of psychosomatic research 65 (4), 389-401, 2008 | 71 | 2008 |